|
Scores in Self-efficacy (GSE), Quality of Life Scale (QOLS-N) and Coping Strategies Scale before the intervention, at the end of the intervention, and six months after the end of the intervention for the treatment (N = 41) and control (N = 28) groups (mean ± SD).1 |
||||||||||||
| Variables |
Score before (SB) |
Score after (SA) |
D.F |
F (SA-SB) |
P |
Score six months after end of intervention (SSMA) |
D.F |
F (SSMA-SB) |
P |
D.F. |
F (SSMA-SA) |
P |
|
|
||||||||||||
| Self-efficacy (GSE) |
||||||||||||
| Treatment group |
23.1 ± 5.12 |
23.5 ± 6.56 |
1,60 |
0.02 |
n.s. |
25.7 ± 5.93 |
1,55 |
4.20 |
0.05 |
1,55 |
5.6 |
0.02 |
| Control group |
25.6 ± 6.40 |
25.3 ± 6.62 |
25.4 ± 5.92 |
|||||||||
|
|
||||||||||||
| Quality of Life Scale (QOLS-N) |
||||||||||||
| Treatment group |
64.3 ± 14.93 |
64.3 ± 17.09 |
1,60 |
0.49 |
n.s. |
66.7 ± 16.86 |
1,57 |
0.38 |
n.s |
1,57 |
0.38 |
n.s |
| Control group |
63.2 ± 14.06 |
64.4 ± 13.52 |
66.0 ± 15.25 |
|||||||||
|
|
||||||||||||
| Coping Strategies Scale |
||||||||||||
| Treatment group |
31.6 ± 8.51 |
32.8 ± 8.67 |
1,60 |
0.01 |
n.s. |
34.3 ± 8.10 |
1,57 |
0.79 |
n.s. |
1,57 |
0.39 |
n.s |
| Control group |
32.2 ± 7.38 |
31.4 ± 8.69 |
31.6 ± 8.02 |
|||||||||
|
1 Analysis of variance (ANOVA) is used to test the differences in means between registration times and groups. | ||||||||||||
Berget et al. Clinical Practice and Epidemiology in Mental Health 2008 4:9 doi:10.1186/1745-0179-4-9 |
||||||||||||